Long-term experience using CNI-free immunosuppression in selected paediatric heart transplant recipients.

Lisa-Maria RosenthalJohannes NordmeyerPeter KramerFriederike DanneConstanze PfitzerFelix BergerKatharina Rose Luise SchmittStephan Schubert

Published in: Pediatric transplantation (2021)

CNI-free immunosuppression based on mTORis is a safe and appropriate strategy for maintenance therapy in selected paediatric patients, significantly improves renal function and stabilises CAV. OCT revealed early development of angiographically silent CAV.

Keyphrases

end stage renal disease
intensive care unit
emergency department
ejection fraction
newly diagnosed
chronic kidney disease
heart failure
peritoneal dialysis
prognostic factors
single cell
optical coherence tomography